15 commercial payer policies list B12. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
15 policies from 2 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Showing 10 of 12 · All Aetna policies
| Policy | Effective | Status of B12 |
|---|---|---|
| Autism Spectrum Disorders | Dec 5, 2023 | Covered |
| Biochemical Markers of Bone Remodeling | Jul 27, 2023 | Covered |
| Complementary and Alternative Medicine | Aug 10, 2023 | Covered |
| Diabetic Neuropathy: Selected Treatments | Feb 20, 2024 | Covered |
| Erythropoiesis Stimulating Agents | Jan 9, 2024 | Covered |
| Evoked Potential Studies | Oct 25, 2023 |
| Extracorporeal Photochemotherapy (Photopheresis) | Mar 29, 2023 | Covered |
|---|
| Homocysteine Testing | Oct 26, 2023 | Covered |
|---|
| Non-myeloablative Hematopoietic Cell Transplantation (Mini-Allograft / Reduced Intensity Conditioning Transplant) | Feb 20, 2024 | Covered |
|---|
| Pemetrexed Products | Feb 20, 2024 | Covered |
|---|
| Policy | Effective | Status of B12 |
|---|---|---|
| Erythropoiesis-Stimulating Agents | Apr 1, 2026 | Covered |
| Kisunla (Donanemab-Azbt) | Feb 1, 2026 | Covered |
| Leqembi (Lecanemab-Irmb) | Apr 1, 2026 | Covered |